Cargando…
SEPROGADIC – serum protein-based gastric cancer prediction model for prognosis and selection of proper adjuvant therapy
Gastric cancer (GC) patients usually receive surgical treatment. Postoperative therapeutic options such as anticancer adjuvant therapies (AT) based on prognostic prediction models would provide patient-specific treatment to decrease postsurgical morbidity and mortality rates. Relevant prognostic fac...
Autores principales: | Ahn, Hee-Sung, Sohn, Tae Sung, Kim, Mi Jeong, Cho, Byoung Kyu, Kim, Su Mi, Kim, Seung Tae, Yi, Eugene C., Lee, Cheolju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237900/ https://www.ncbi.nlm.nih.gov/pubmed/30442939 http://dx.doi.org/10.1038/s41598-018-34858-x |
Ejemplares similares
-
Adjuvant Treatment of Proper Endobronchial Management in Leiomyosarcoma
por: Kim, Soo Jung, et al.
Publicado: (2013) -
Multiple Primary Malignancies in Patients with Multiple Early Gastric Cancer
por: Kim, Dae Hoon, et al.
Publicado: (2017) -
Adjuvant Chemotherapy with or without Concurrent Radiotherapy for Patients with Stage IB Gastric Cancer: a Subgroup Analysis of the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Phase III Trial
por: Kim, Youjin, et al.
Publicado: (2018) -
Proper adjuvant therapy in patients with borderline resectable and locally advanced pancreatic cancer who had received neoadjuvant FOLFIRINOX
por: Choi, Jin Ho, et al.
Publicado: (2022) -
Adjuvant Chemotherapy in Microsatellite Instability–High Gastric Cancer
por: Kim, Jin Won, et al.
Publicado: (2020)